MedTrace Logo

VividFlo System Validation Study

NCT07754201 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-08-10

No results posted yet for this study

Summary

This is a 10-participant study to assess the VividFlo System and surgical implantation using a modified technique.

Conditions

Interventions

DEVICE

VividFlo System

Subconjunctival surgical implantation of the VividFlo Glaucoma Implant (VW-51) in one eye using the VividFlo System and a partial-thickness scleral flap technique.

Sponsors & Collaborators

  • VividWhite Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Michael Coote · Melbourne Eye Specialists

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-10
Primary Completion
2027-12-31
Completion
2028-03-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07754201 on ClinicalTrials.gov